Showing results (71-80 of 160) with videos related to
Sort By:
Pageof 16
Journal of Immunology (Baltimore, Md. : 1950)|August 5, 2006
Opposite fate of endocytosed CCR7 and its ligands: recycling versus degradationCarolina Otero, Marcus Groettrup, Daniel F LeglerBiomolecules|June 27, 2020
Regulation of Interferon Induction by the Ubiquitin-Like Modifier FAT10Mei Min Mah, Nicola Roverato, Marcus GroettrupFEBS Letters|December 8, 2016
Newly translated proteins are substrates for ubiquitin, ISG15, and FAT10Valentina Spinnenhirn, Annegret Bitzer, Annette Aichem, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|June 20, 2012
Coencapsulation of tumor lysate and CpG-ODN in PLGA-microspheres enables successful immunotherapy of prostate carcinoma in TRAMP miceMarc Mueller, Wilfried Reichardt, Julia Koerner, et al.International Journal of Cancer|January 6, 2011
Tumor eradication by immunotherapy with biodegradable PLGA microspheres--an alternative to incomplete Freund's adjuvantMarc Mueller, Eva Schlosser, Bruno Gander, et al.Trends in Biochemical Sciences|March 21, 2008
Activating the ubiquitin family: UBA6 challenges the fieldMarcus Groettrup, Christiane Pelzer, Gunter Schmidtke, et al.Brain, Behavior, and Immunity|May 2, 2017
Chronic stress suppresses anti-tumor TCD8+ responses and tumor regression following cancer immunotherapy in a mouse model of melanomaAnnette Sommershof, Lisa Scheuermann, Julia Koerner, et al.The Journal of Biological Chemistry|February 6, 2004
NEDD8 ultimate buster-1L interacts with the ubiquitin-like protein FAT10 and accelerates its degradationMark Steffen Hipp, Shahri Raasi, Marcus Groettrup, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|August 16, 2015
Cytotoxic T cell vaccination with PLGA microspheres interferes with influenza A virus replication in the lung and suppresses the infectious diseaseValerie L Herrmann, Carmen Hartmayer, Oliver Planz, et al.Journal of Virology|July 5, 2012
Stable antigen is most effective for eliciting CD8+ T-cell responses after DNA vaccination and infection with recombinant vaccinia virus in vivoChristopher Schliehe, Annegret Bitzer, Maries van den Broek, et al.Pageof 16